发明申请
US20110150827A1 5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITORS
有权
5,5-FUSED ARYLENE或HETEROARYLENE HEPATITIS C VIRUS INHIBITORS
- 专利标题： 5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITORS
- 专利标题（中）： 5,5-FUSED ARYLENE或HETEROARYLENE HEPATITIS C VIRUS INHIBITORS
-
申请号： US12972254申请日： 2010-12-17
-
公开(公告)号： US20110150827A1公开(公告)日： 2011-06-23
- 发明人: Cyril B. Dousson , David Dukhan , Christophe Claude Parsy , Claire Pierra , Francois-Rene Alexandre , Guillaume Brandt , Daniel Da Costa , Houcine Rahali , Jean-Laurent Paparin , Michel Derock , Thierry Convard , Dominique Surleraux
- 申请人： Cyril B. Dousson , David Dukhan , Christophe Claude Parsy , Claire Pierra , Francois-Rene Alexandre , Guillaume Brandt , Daniel Da Costa , Houcine Rahali , Jean-Laurent Paparin , Michel Derock , Thierry Convard , Dominique Surleraux
- 申请人地址： US MA Cambridge
- 专利权人： Idenix Pharmaceuticals, Inc.
- 当前专利权人： Idenix Pharmaceuticals, Inc.
- 当前专利权人地址： US MA Cambridge
- 主分类号： A61K38/20
- IPC分类号： A61K38/20 ; C07D513/04 ; C07D498/04 ; C07D495/04 ; C07D487/04 ; C07D491/048 ; A61K31/429 ; A61K31/424 ; A61K31/4178 ; A61K31/5377 ; A61K31/4025 ; A61K31/433 ; A61K38/21 ; A61K31/7056 ; A61K31/7088 ; A61P31/14 ; A61P1/16 ; A61P31/12 ; C12N7/06
摘要：
Provided herein are 5,5-fused heteroarylene hepatitis C virus inhibitor compounds, for example, of Formula I, IA, or IB, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
公开/授权文献
信息查询
IPC分类:
